Methods for determining neurotransmitter metabolism markers for clinical diagnostics


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Published data describing the current status and prospects for the development of clinical diagnostics of a number of neurodegenerative and neuroendocrine diseases associated with neurotransmitter balance disorders in a human body are generalized, systematized, and assessed in the review. Characteristics, advantages, and limitations of neuroimaging techniques and different diagnostic methods based on measuring concentrations of protein markers, catecholamines, and their metabolites are discussed. Prospects of the application of optical methods, such as fluorimetry and surface-enhanced Raman spectroscopy, to the development of sensor systems for the diagnosis of these diseases by the concentration of catecholamines and their metabolites in biological fluids are demonstrated.

作者简介

I. Veselova

Department of Chemistry; National Research Centre “Kurchatov Institute”

编辑信件的主要联系方式.
Email: irina.veselova@mail.ru
俄罗斯联邦, Moscow, 119991; Moscow, 123098

E. Sergeeva

Department of Chemistry

Email: irina.veselova@mail.ru
俄罗斯联邦, Moscow, 119991

M. Makedonskaya

Department of Chemistry; National Research Centre “Kurchatov Institute”

Email: irina.veselova@mail.ru
俄罗斯联邦, Moscow, 119991; Moscow, 123098

O. Eremina

Department of Chemistry; National Research Centre “Kurchatov Institute”

Email: irina.veselova@mail.ru
俄罗斯联邦, Moscow, 119991; Moscow, 123098

S. Kalmykov

Department of Chemistry; National Research Centre “Kurchatov Institute”

Email: irina.veselova@mail.ru
俄罗斯联邦, Moscow, 119991; Moscow, 123098

T. Shekhovtsova

Department of Chemistry

Email: irina.veselova@mail.ru
俄罗斯联邦, Moscow, 119991


版权所有 © Pleiades Publishing, Ltd., 2016
##common.cookie##